Skip to content
  • Sunday, 26 July 2026
  • 4:32 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • University of Florida Study Suggests Popular Joint Supplement Glucosamine May Accelerate Cognitive Decline in Alzheimer’s Patients
Neuroscience & Brain Research

University of Florida Study Suggests Popular Joint Supplement Glucosamine May Accelerate Cognitive Decline in Alzheimer’s Patients

Rifan Muazin Jun 27, 2026 0

A groundbreaking study led by researchers at the University of Florida has uncovered a potential link between the use of…

Read More
Neuroscience & Brain Research

Popular Anti-Aging Drug Combination Linked to Significant Myelin Damage and Brain Deterioration in UConn Study

Rifan Muazin Jun 4, 2026 0

A pharmaceutical combination that has become a cornerstone of modern anti-aging and longevity research may pose a severe risk to…

Read More
Neuroscience & Brain Research

Popular Anti-Aging Drug Combination Linked to Significant Brain Damage and Myelin Loss in New Study

Rifan Muazin May 27, 2026 0

A drug combination that has become a cornerstone of modern longevity research may carry unforeseen and devastating consequences for neurological…

Read More
Unlocking the Genetic Code’s Hidden Language: Scientists Discover Cellular Quality Control for Codon EfficiencyRethinking the Arrow of Time: New Research Challenges Assumptions Underlying the Boltzmann Brain HypothesisCal Poly Researchers Advance Quantum Computing Through Flux-Switching Floquet Engineering and Time-Dependent Magnetic FieldsStanford Researchers Discover Protein Inhibitor That Reverses Cartilage Loss and Prevents Osteoarthritis
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ